Delee is a Texas-based company dedicated to changing the way cancer is detected, monitored, and treated to increase patients’ chances of defeating the disease. Delee was founded by Alejandro Abarca, Liza Velarde, and Juan Felipe Yee with a mission to create technological and innovative solutions that increase quality of life and help as many people as possible.
Delee has developed the CytoCatch, which is a highly sensitive device capable of rapidly isolating and analyzing circulating tumor cells (CTCs)from blood samples. CTCs are malignant cells that are shed from tumors and travel into vascular and lymphatic systems. The ability to detect these cells in the bloodstream can help detect cancer in its early stages, monitor the evolution of the disease, and personalize treatment.
The CytoCatch fully automates the isolation and analysis ofCTCs. CTCs are dyed with fluorescent antibodies to differentiate between malignant cells and normal blood. An imaging system using an artificial intelligence algorithm will automatically perform a classification and enumeration of the captured CTCs based on their morphology and the expression of specific antigens. By detecting cancer in its early stages, treatment can be personalized to the patient and increase their chances of defeating the disease. And because the CytoCatch automates testing, it reduces human error in handling samples and interpreting results.
Delee expects to obtain FDA approval for the CytoCatch technology in 2023. Prior to obtaining FDA approval for the CytoCatch, Delee plans to sell it for research to pharmaceutical companies and researchers. Once the technology obtains theFDA approval, Delee will commercialize it as a diagnostic medical device to hospitals and laboratories.
Do For You?
Delee is in the early stages of making the CytoCatch available to pharmaceutical companies and researchers. Once it has been made widely available, Delee believes it will revolutionize the way cancer is detected, monitored, and treated. Their goal is to help patients receive early detection of cancer and support their chances of defeating the disease. It will also help doctors and researchers treat their patients effectively and efficiently.
How Can You Get Involved
Delee is currently raising funds through a crowd-funding campaign. If you’d like to help in their mission to change the way cancer is detected, monitored, and treated, making an investment is a great way to get involved. You can click here to learn more about their fundraising campaign and make an investment.
If you have any questions or feedback for Delee, you can contact them through their website here. You’ll also find in-depth information about how the CytoCatch technology works and the benefits it can offer to the medical community.